[H-B-VAX II hepatitis B vaccine (recombinant) produced at the MSD Research Laboratories. Description of the vaccine].
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D017325:Hepatitis B Vaccines; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D007273:Injections, Intramuscular; D009426:Netherlands; D011044:Poland; D011995:Recombination, Genetic; D012441:Saccharomyces cerevisiae / Q000235:genetics; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage / Q000276:immunology* / Q000633:toxicity
D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines
H-B-VAX II szczepionka przeciw hepatitis B (rekombinowana), MSD. Opis.